MDB Capital Holdings Announces Transitions In Its Board of Directors
Rhea-AI Summary
MDB Capital Holdings (NASDAQ: MDBH) announced board transitions effective February 1, 2026. Jeb Terry, Sr. was appointed to the board; Susanne L. Meline concluded her board service and will remain a shareholder and advocate. The company cited Terry's two decades in microcap life sciences investing and his leadership at Aberdeen Investment Management (2010–2025).
MDB said these changes support its strategy to scale a public venture platform that launches and finances early-stage, category-leading companies.
Positive
- Board appointment: Jeb Terry, Sr. added to board effective February 1, 2026
- Relevant experience: Terry led Aberdeen Investment Management from 2010–2025 with microcap life sciences focus
Negative
- None.
News Market Reaction – MDBH
In the Feb 3 session, MDBH declined 3.13%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service
Addison, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today announced the appointment of Jeb Terry, Sr to its Board of Directors and extended its sincere gratitude to Susanne Meline as she concluded her dedicated and influential board service. Both transitions are effective as of February 1, 2026.
Jeb Terry brings to the MDB board more than two decades of investment in microcap medical and biotechnology companies, where he has consistently identified and capitalized on high-potential opportunities in this dynamic and innovation-driven sector. He founded and served as President of Aberdeen Investment Management LLC from 2010 through 2025 where he led investment strategy and portfolio management with a sharp focus on undervalued microcap opportunities in life sciences. Drawing on a broad and distinguished career spanning venture capital, leveraged buyouts, and public equities, Mr. Terry brings a multifaceted perspective to investment decision-making.
“Jeb has been an active and avid supporter of MDB as we have grown from a private company to a publicly traded leader in public venture,” said Christopher Marlett, Co-founder and CEO of MDB. “We are excited to add his deep insight and sharp focus to our board as we continue to scale the platform and expand our founder and investor community.”
Concurrently, Susanne L. Meline concludes her service to the MDB board following years of invaluable leadership and guidance with a specialty in both finance and law. She will remain an enthusiastic shareholder and advocate of public venture for innovative, early-stage companies.
“We are deeply grateful to Susanne for all she has contributed to our board and the success of MDB,” said Christopher Marlett, Co-founder and CEO of MDB. “She has played an integral role in shaping the board’s impact and advising our leadership team as we transform how compelling technologies and companies are financed and commercialized through our platform.”
These transitions reflect MDB’s commitment to building a world-class leadership team to support its strategy of launching and scaling game-changing companies through its premier public venture platform.
About MDB Capital Holdings, LLC
Founded in 1997, MDB Capital focuses on launching "Big Ideas" through a unique approach to public venture capital. The firm emphasizes community-driven financings of early-stage leaders in significant business and technology categories via early public offerings, primarily on NASDAQ, as well as post-IPO offerings for qualifying companies. MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand.
For more information, please visit www.mdb.com
Forward-Looking Statements
This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms
or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.
Securities trading, account management, and investment banking services are offered by MDB Capital, a wholly owned subsidiary of MDB Capital Holdings, LLC (Nasdaq: MDBH) and a registered broker-dealer and member of FINRA and SIPC. Unless clearly stated, nothing herein shall be construed to be an offer to sell, nor a solicitation of an offer to buy, any financial product. For more information, please refer to MDB Capital’s Client Relationship Summary, or Form CRS, the uniform disclosure that provides succinct information about a firm’s services and responsibilities, fees and costs, and standards of conduct, at: https://www.mdb.com/disclosures/customer-relationship-summary/
Investor Relations Contact:
IR@mdb.com
Media Contact:
press@mdb.com
